Enteric Fever, commonly known as typhoid fever, continues to be a significant public health concern worldwide. With the emergence of multidrug-resistant strains and the increasing global travel, the management of this disease has become more challenging. This article aims to provide an overview of the recent advancements and best practices in the management of Enteric Fever.
Accurate and timely diagnosis remains a cornerstone in the management of Enteric Fever. Recent advancements include the introduction of rapid diagnostic tests (RDTs) and nucleic acid amplification tests (NAATs). These tests have shown improved sensitivity and specificity, enabling early detection and treatment initiation.
Antimicrobial resistance has necessitated a shift towards new treatment regimens. The current recommended first-line treatment involves the use of third-generation cephalosporins like ceftriaxone or fluoroquinolones. The use of azithromycin has also shown promising results, especially in areas with high fluoroquinolone resistance.
Vaccination remains a critical preventive measure. The newer conjugate vaccines, such as Typbar-TCV®, have shown higher efficacy and longer-lasting immunity compared to earlier vaccines. These vaccines are now recommended for routine use in high-risk areas and for travelers to these regions.
Public health measures, including improved sanitation, safe water supply, and food safety practices, continue to play a vital role in controlling the spread of Enteric Fever. Health education and promotion of hygiene practices are also essential in preventing the disease.
In conclusion, the management of Enteric Fever has seen significant advancements in recent years. However, the emergence of drug-resistant strains necessitates ongoing research and innovation. It is crucial for healthcare professionals to stay updated with the latest developments and best practices to provide optimal care to patients.
1.
Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results
2.
FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer
3.
How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace
4.
AI-based liquid biopsy shows promise for detecting brain cancer
5.
The Kansas Cancer Center awarded two Indian American doctors professorships.
1.
Clinical Guidelines for Targeting the Tumor Microenvironment in Solid Cancers
2.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
3.
Examining Serum Osmolality: What It Is And How To Test For It
4.
Evolutionary Bottlenecks in Tumor Progression
5.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Thromboprophylaxis In Medical Settings
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation